|
|
||||||||
Technical Briefs |
1
Hennepin County Medical Center, Clinical Laboratories, Minneapolis MN 55415
2
Department of Physiology, Queens University, Kingston, Ontario, K7L 3N6 Canada
a author for correspondence: fax 612-904-4229; e-mail
fred.apple@co.hennepin.mn.us
Recent publications of consensus documents for the redefinition
of myocardial infarction are heavily predicated on the role of
increases in cardiac troponin (I or T) in serum in the setting of
ischemic symptoms (1)(2)(3)). Cardiac troponin T (cTnT)
has also been reported to be a predictor of mortality in patients with
end stage renal disease (4)(5). An unexplained
increase in the frequency of increased serum cTnT compared with serum
cardiac troponin I has been described in these patients
(6)(7). Explanations advanced for this
difference include the possibility of nonspecific reactions in the cTnT
assay or de novo expression of cTnT in skeletal muscle of renal
diseased patients that is subsequently released into the serum
(8). However, recent studies on skeletal muscle from renal
disease patients have shown that although the two antibodies used in
the cTnT diagnostic assay (M7 and M11.7) individually bind to muscle
proteins, this would not cause false-positive results in the
current-generation cTnT assay marketed by Roche (8). On the
other hand, cardiac troponin I is not expressed in fetal or in healthy
or diseased adult human skeletal tissue (9). An additional
possibility is that cTnT or other immunoreactive proteins are being
expressed
References
The following articles in journals at HighWire Press have cited this article:
![]() |
M. S. Willis, J. A. Snyder, R. H. Poppenga, and D. G. Grenache Bovine cardiac troponin T is not accurately quantified with a common human clinical immunoassay J Vet Diagn Invest, January 1, 2007; 19(1): 106 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis Circulation, November 15, 2005; 112(20): 3088 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ritter, P. A. Lee, J. F. Taylor, L. Hsu, J. D. Cohen, H. D. Chung, and K. S. Virgo Troponin I in Patients without Chest Pain Clin. Chem., January 1, 2004; 50(1): 112 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Freda, W. H. W. Tang, F. Van Lente, W. F. Peacock, and G. S. Francis Cardiac troponins in renal insufficiency: Review and clinical implications J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2065 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe Testing the wrong hypothesis: the failure to recognize the limitations of troponin assays J. Am. Coll. Cardiol., October 1, 2001; 38(4): 999 - 1001. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |